Results 101 to 110 of about 28,830 (241)

Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel

open access: yesAIDS Research and Treatment, 2017
This study assessed the effect of efavirenz mid-dose plasma concentrations on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among 49 HIV infected women coadministering ethinylestradiol/levonorgestrel, including 34 HIV ...
Grant Munkwase   +3 more
doaj   +1 more source

Over Exposure to Efavirenz Plasma Concentrations among Beninese HIV Patients Treated by A 600 mg Daily Dose [PDF]

open access: hybrid, 2017
Allabi Aurel Constant   +4 more
openalex   +1 more source

Do non-nucleoside reverse transcriptase inhibitors contribute to lipodystrophy?

open access: yes, 2005
Lipodystrophy complications, including lipoatrophy (pathological fat loss) and metabolic complications, have emerged as important long-term toxicities associated with antiretroviral therapy in the current era. The wealth of data that has accumulated over
Nolan, D.
core  

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens [PDF]

open access: gold, 2005
Susan Swindells   +9 more
openalex   +1 more source

Contribution of N-Glucuronidation to Efavirenz Elimination In Vivo in the Basal and Rifampin-Induced Metabolism of Efavirenz

open access: yes, 2011
In this study, the contribution of efavirenz N-glucuronidation to efavirenz elimination in vivo was assessed. In a two-period placebo-controlled crossover trial design, a single 600-mg oral dose of efavirenz was administered to ...
David Jones   +3 more
core   +1 more source

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial [PDF]

open access: gold, 2017
on behalf of the MONOD Study Group   +21 more
openalex   +1 more source

A concise flow synthesis of Efavirenz

open access: yes, 2015
Efavirenz is an essential medicine for the treatment of HIV, which is still inaccessible to millions of people worldwide. A novel, semi‐continuous process provides rac‐Efavirenz with an overall yield of 45 %. This streamlined proof‐of‐principle synthesis
Kerry Gilmore   +7 more
core   +1 more source

Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi [PDF]

open access: bronze, 2015
Leonardo Palombi   +15 more
openalex   +1 more source

Pembentukan Dispersi Padat Efavirenz - Crospovidone [PDF]

open access: yes, 2015
ABSTRAK Efavirenz merupakan non-nucleosid reverse transcriptase inhibitor (NNRTI) yang digunakan untuk mengatasi infeksi human immunodeficiency virus (HIV) tipe 1.
Fajriani, Aisyah
core  

Home - About - Disclaimer - Privacy